Life Sciences Research for Lifelong Health

The Babraham Institute undertakes world-leading research into understanding the biology of how our bodies work, including what changes as we age and during disease. Our research is split into four programmes: Epigenetics, Signalling, Lymphocyte Signalling and Nuclear Dynamics, supported by strategic programme grants from the Biotechnology and Biological Sciences Research Council (BBSRC) and additional funding from research councils, the EU and charities.

We maximise the impact of our research through Knowledge Exchange, Commercialisation and Public Engagement activities. We do this by collaborating with other academics, policy makers, charities, schools, the general public and industry, including companies on the Babraham Research Campus. Commercialisation is achieved in collaboration with the Institute’s wholly-owned trading arm, Babraham Institute Enterprise Limited.


05/12/2017

Institute wins national Openness Award

Ongoing partnership with Dutch school finds success

Award recognises efforts to engage students with research using…


17/11/2017

Epigenetics helps keep the immune system running

Dr Anne Corcoran's team examines the role of epigenetics in antibody production

Markers in the genome control how often certain genes are used…


16/11/2017

Learning from science insights

Sarah and Helen visit the Institute to find out about our work

By providing training to teachers the Institute helps to enrich…

Access our Science Services

Biological Support Unit
Imaging
Bioinformatics
Sequencing
Gene Targeting
Lipidomics
Biological Chemistry
Mass Spectrometry
Flow Cytometry
Biological Support Unit
Our state-of-the-art Biological Support Unit provides housing and care for pathogen-free rodents used in the academic research programmes and by private companies
Imaging

The Imaging Facility provides supported access to advanced fluorescence imaging technologies and image analysis solutions.

Bioinformatics
The bioinformatics group provides an interface between the computational infrastructure of the insitute and the biology performed within the research groups
Sequencing
The Facility plays a crucial role in all the Institute’s research programmes and is also available to external users on a fee-for-service basis
Gene Targeting
Providing a complete service to generate genetically altered mouse strains for Babraham Institute research groups and external companies
Lipidomics
We have established methods to analyse neutral lipids, phospholipids and sphingolipids using a Shimadzu IT-TOF mass spectrometer coupled to a Prominence HPLC system
Biological Chemistry
Biological chemistry is the interface between chemistry and biology, requiring both synthetic organic chemistry skills and a knowledge of biochemistry
Mass Spectrometry
The Mass Spectrometry Facility is housed in a purpose-built laboratory in a new building in the centre of the campus
Flow Cytometry
The Babraham Institute Flow Cytometry Core Facility offers high quality service and state-of-the-art instrumentation to members of Babraham Institute and external users.

14/12/2017

RNA modifications as regulators of stem cell function

Dr Michaela Frye; Department of Genetics, WT-MRC Stem Cell Institute,…


05/08/2018

Chromos at ZKM 'Open Codes' Exhibition

Find Chromos virtual reality (VR) experience in Karlsruhe, Germany


07/03/2018

Schools' Day 2018

t

 

Key visitor pages

Academia

The following pages may be of particular interest to those in the Academic community:

Media

Members of the media and journalists may wish to visit the following sections for further details about our work:

Public

Members of the public may wish to look at the following pages to find out how the Babraham Institute works with and for society:

Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis.

Kishore M, Cheung KCP, Fu H

Immunity
47 1097-4180:875-889.e10 (2017)

PMID: 29166588

BioModels: expanding horizons to include more modelling approaches and formats.

Glont M, Nguyen TVN, Graesslin M

Nucleic acids research
1362-4962: (2017)

PMID: 29106614